Medical News

RSS

Drug shortages have tripled during the last six years

The drugs are among hundreds that have been in short supply at the nation's hospitals, and more recently, community pharmacies.

28 Jun 2011

TrialNet presents Diamyd Phase II study results on type 1 diabetes at ADA 2011

The American research consortium Type 1 Diabetes TrialNet presented their results of a Phase II study with the antigen-based diabetes therapy Diamyd yesterday, June 27, at the American Diabetes Association 71st Scientific Sessions (ADA) in San Diego, California, USA, after the closing of the stock market.

28 Jun 2011

Yale University: Gabapentin clinical study on epilepsy may have been a 'seeding trial'

Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according to a report in the June issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

28 Jun 2011

Women can benefit from immediate breast reconstruction following mastectomy

For women undergoing mastectomy for breast cancer, immediate breast reconstruction has a low risk of complications—including serious complications related to radiation therapy—and does not cause undue delays in cancer treatment, reports a study in the July issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

28 Jun 2011

ChemoCentryx CCX140 Phase II study on type 2 diabetes meets primary endpoint

ChemoCentryx, Inc. today announced that CCX140, the Company's novel, orally active CCR2 antagonist successfully met its primary endpoint of safety and tolerability and demonstrated clinical efficacy in a Phase II study in patients with type 2 diabetes on stable doses of metformin.

28 Jun 2011

Researchers, policy experts to examine issue of declining enrollment in clinical trials

Leading researchers and policy experts from across the country will come together June 27 and June 28 at Mount Sinai School of Medicine in New York to examine the issue of declining enrollment in clinical trials.

28 Jun 2011

Marshall Edwards' Triphendiol pre-clinical study data now available in Anti-Cancer Drugs website

Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.

28 Jun 2011

Body sculpting technique eliminates abdominal fat with few side effects

A "body sculpting" technique using high-intensity focused ultrasound to eliminate unwanted abdominal fat effectively reduces waist circumference, with only minor pain and side effects, reports a study in the July issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

28 Jun 2011

FDA hearing on breast cancer drug set for this week

Genentech, the maker of Avastin, will appeal to the Food and Drug Administration to make its drug available as a treatment for breast cancer — asking for one more chance to prove its efficacy.

28 Jun 2011

FDA approves Althea's PAI to manufacture commercial parenteral product

Althea Technologies, Inc. announced today that following a comprehensive FDA Pre-Approval Inspection (PAI) in April 2011, it has received a license to manufacture and package a commercial parenteral product for the US market.

28 Jun 2011

RWJF launches comprehensive health care online directory for patients

The Robert Wood Johnson Foundation today launched the nation's most comprehensive online directory for patients to find reliable information on the quality of health care provided by physicians and hospitals in their communities.

28 Jun 2011

Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancer

Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.

28 Jun 2011

Microbix renegotiates key terms of Hunan influenza vaccine joint venture

Microbix Biosystems Inc., a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and biological products announced today that it is renegotiating key terms of the original joint venture agreement with their Joint Venture partner Hunan Biopharmaceutical Co. Ltd.

28 Jun 2011

Circulation journal publishes Celladon's MYDICAR Phase 2 trial on advanced heart failure

Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announces that the data from its completed Phase 2 CUPID clinical study of MYDICAR for the treatment of advanced heart failure is being published today online in Circulation, an American Heart Association journal.

28 Jun 2011

New software program can allow scientists to produce single brain images

A University of Colorado Boulder research team has developed a new software program allowing neuroscientists to produce single brain images pulled from hundreds of individual studies, trimming weeks and even months from what can be a tedious, time-consuming research process.

28 Jun 2011

India close to eradicating polio

"Scientists, health workers and community outreach officials in India believe they're finally on the cusp of a major milestone, the defeat of polio throughout the country," the Los Angeles Times reports.

28 Jun 2011

RL Solutions, 3M to offer new software for minimizing risk of healthcare-acquired infections

3M Infection Prevention and RL Solutions today announced a joint feasibility program to provide healthcare facilities data on the rate of infection in real-time and the costs associated with those infections.

28 Jun 2011

Spirituality, religion can help traumatic brain injury victims to rehabilitate

Brigid Waldron-Perrine, Ph.D., a recent graduate from Wayne State University, and her mentor, Lisa J. Rapport, Ph.D., professor of psychology at Wayne State University's College of Liberal Arts and Sciences, found that if traumatic brain injury (TBI) victims feel close to a higher power, it can help them rehabilitate. The study was recently published in Rehabilitation Psychology.

28 Jun 2011

UNICEF representative warns Filipino children displaced after flooding face disease risk

About 450,000 children, displaced by severe flooding in the southern Philippines, could face an outbreak of diarrhea and pneumonia, Vanessa Tobin, UNICEF's representative in the Philippines, said on Sunday, Agence France-Presse reports.

28 Jun 2011

Accelerated hepatitis B vaccination schedule effective for high-risk pregnant women

UT Southwestern Medical Center maternal-fetal specialists have confirmed a potential new protocol to protect pregnant women who are at risk for hepatitis B, a health problem that affects 2 billion people worldwide.

28 Jun 2011

Medical News

Drug shortages have tripled during the last six years

TrialNet presents Diamyd Phase II study results on type 1 diabetes at ADA 2011

Yale University: Gabapentin clinical study on epilepsy may have been a 'seeding trial'

Women can benefit from immediate breast reconstruction following mastectomy

ChemoCentryx CCX140 Phase II study on type 2 diabetes meets primary endpoint

Researchers, policy experts to examine issue of declining enrollment in clinical trials

Marshall Edwards' Triphendiol pre-clinical study data now available in Anti-Cancer Drugs website

Body sculpting technique eliminates abdominal fat with few side effects

FDA hearing on breast cancer drug set for this week

FDA approves Althea's PAI to manufacture commercial parenteral product

RWJF launches comprehensive health care online directory for patients

Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancer

Microbix renegotiates key terms of Hunan influenza vaccine joint venture

Circulation journal publishes Celladon's MYDICAR Phase 2 trial on advanced heart failure

New software program can allow scientists to produce single brain images

India close to eradicating polio

RL Solutions, 3M to offer new software for minimizing risk of healthcare-acquired infections

Spirituality, religion can help traumatic brain injury victims to rehabilitate

UNICEF representative warns Filipino children displaced after flooding face disease risk

Accelerated hepatitis B vaccination schedule effective for high-risk pregnant women

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News